Underlying disorders associated with severe early-onset preeclampsia.
about
Interventions for preventing pre-eclampsia and its consequences: generic protocolHeparin for pregnant women with acquired or inherited thrombophiliasThrombophilia and pregnancyLow-molecular-weight heparin for the prevention of obstetric complications in women with thrombophiliasAntiphospholipid syndrome in obstetricsPre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medicationThrombophilia and pregnancy: review of the literature and some original data.Low-molecular-weight heparin for thrombophilia in pregnant women.Preventive effects of folic acid supplementation on adverse maternal and fetal outcomes.Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant ratsMethylenetetrahydrofolate reductase polymorphism and pre-eclampsia.Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia.Thrombophilia mediates lowering cardiovascular risk factors in women with a history of preeclampsia.Homocysteine.Association of early-onset pre-eclampsia in first pregnancy with normotensive second pregnancy outcomes: a population-based study.The detection, investigation and management of hypertension in pregnancy: full consensus statement.Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control studyIncreased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restrictionThe pathogenesis of pre-eclampsia: new aspects.Roles of homocysteine in cell metabolism: old and new functions.Natural coagulation inhibitors and active protein c resistance in preeclampsia.Hyperhomocysteinaemia and human reproduction.Low-molecular-weight heparins during pregnancyThe many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism.MTHFR (C677T) polymorphism and PR (PROGINS) mutation as genetic factors for preterm delivery, fetal death and low birth weight: A Northeast Indian population based studyChanges in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort studyMy approach to performing a perinatal or neonatal autopsyAnnexin A1 Is Increased in the Plasma of Preeclamptic Women.Prenatal screening for thrombophilia: the background and the approach.Folic acid - vitamin and panacea or genetic time bomb?Short-term outcome of patients with preeclampsiaPregnancy and thrombophilia.Genes and the preeclampsia syndrome.Fatal postpartum spontaneous liver rupture: case report and literature review.Effects of methionine synthase and methylenetetrahydrofolate reductase gene polymorphisms on markers of one-carbon metabolism.First-trimester maternal serum PP13 in the risk assessment for preeclampsia.Maternal near miss and death among women with severe hypertensive disorders: a Brazilian multicenter surveillance study.Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
P2860
Q24244724-D704086A-CC3D-4F25-805E-8D2095CD7414Q24248689-4D00D21B-4DD9-4AB3-94BA-9865F4EE0F0AQ24801115-5CB43CEB-63F6-49EA-99F0-B0430A998ADFQ28193116-E8EDDE93-2AAF-4193-B945-2E73F7156FB7Q28196482-36285CC4-456C-459D-98F8-84E91A1D6988Q28217455-4D204435-72EB-4B30-9661-87A66DCA50D1Q30665115-2B129E82-862A-46B4-9B16-46B6C246137BQ33332833-384419ED-D84A-411B-8AE3-2E7CC70CBCB6Q33632110-369567FC-D9BF-483D-B051-243D2CBDF397Q33650241-C318BC69-B2C3-4F48-8F45-66DACF94B129Q33666694-73A31A99-6985-417F-AD4F-241115F2DEDCQ33679047-70ABE686-AF7C-4EF0-8CE0-D31DC468A4FBQ33686011-77FEC9B9-A5E4-4F6C-8BF2-F0697EA9BF66Q33699211-A62FAF27-5395-4D91-B516-15E03556CA22Q33732664-A0BEB156-CF76-492B-A8F0-9B88FC639103Q33907543-D058B0DA-2809-4EE0-82C5-FC865286B5C6Q33990742-8192F4F2-9360-4937-9AA2-5C84D2C314B7Q34072122-9460B0F8-9149-4FBE-862B-8D709A22D941Q34077721-7B059350-A26F-4940-874D-02F0A109F7EAQ34129720-EE01CD92-7B61-4BB1-907A-ECBE2FA53775Q34308857-4864C34B-C365-4996-BAF9-CDAB3182DD92Q34393988-D711AB76-19DD-4240-ABAA-D76BBD20141CQ34395837-CF563DBD-7ADA-4171-9CD4-33391B7842DAQ34654165-8AD5CCAD-5189-4F72-943C-8D99F44EC539Q35038291-57FF531B-8244-417D-97AF-68AC998A086BQ35087360-4B99EB36-8476-429A-A8E4-11E143B0A69DQ35542199-205BE6C3-3E58-4C2C-B5F7-88421C4F5F1CQ35720653-2D823FD0-B552-4F02-8FA1-78A86A0242A2Q35770185-2F356C64-D2D1-4C39-8126-DEC09A2407F7Q35784972-884C992B-3722-4021-87A2-66AD5C1B34F6Q36030393-58FF319D-B0BB-4C48-B258-12C7AEE223BDQ36058443-A6CA4C45-3EC0-4402-A268-BD4364D4D722Q36776897-EE5EE07D-ED47-471B-8CCE-727E3841CA69Q36867306-D026FEED-8D7F-4D9E-932A-93B882438EF1Q37053831-44993F0F-A828-41D7-8F47-D14D0B6EFAD4Q37119157-63B78BB4-88B8-4316-A725-5154E60E2FDDQ37300036-39A06FFD-66A8-4C87-94BE-A3D7E270B992Q37444801-CA8D0B0E-A9B3-425E-967E-384A4F7ABBE1Q37497141-5C5861E7-0766-44C6-9E6E-E8E6A6DD97A0Q38040182-5CCBCD0C-4649-454D-A4F9-4716F6B26CE6
P2860
Underlying disorders associated with severe early-onset preeclampsia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Underlying disorders associated with severe early-onset preeclampsia.
@en
type
label
Underlying disorders associated with severe early-onset preeclampsia.
@en
prefLabel
Underlying disorders associated with severe early-onset preeclampsia.
@en
P2093
P1476
Underlying disorders associated with severe early-onset preeclampsia.
@en
P2093
Doelitzsch PM
Huijgens PC
de Vries JI
van Geijn HP
von Blomberg BM
P304
P356
10.1016/0002-9378(95)91324-6
P407
P577
1995-10-01T00:00:00Z